In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization ...
Please provide your email address to receive an email when new articles are posted on . A trial of a gold-tipped contact force-sensing catheter for treatment of patients with atrial flutter met its ...
Please provide your email address to receive an email when new articles are posted on . Real-world data show pulsed field ablation was safe and associated with 1-year freedom from atrial fibrillation ...
MARLBOROUGH, Mass., Dec. 28, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE™ ...
Narrow QRS complexes occur regularly. This tracing suggests either atrial flutter or ventricular tachycardia. It is not atrial flutter, however. If it were, the QRS complexes occurring regularly would ...
Q: I’m a 67-year-old man who developed typical atrial flutter two years ago, but I haven’t had any symptoms that I am aware of. I don’t have a history of heart problems. My heart rate was 117 bpm ...
STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital is among the first in the country to successfully treat persistent atrial fibrillation and typical atrial flutter using a ...
Do vitamin K antagonists affect COPD outcomes? New cohort data explore exacerbation and mortality risk compared with DOACs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results